{"title":"更正“在现实世界的临床环境中，沙克比利-缬沙坦治疗心力衰竭伴射血分数降低的早期经验”。","authors":"","doi":"10.1002/ehf2.15211","DOIUrl":null,"url":null,"abstract":"<p>\n <span>Nordberg Backelin, C.</span>, <span>Fu, M.</span>, and <span>Ljungman, C.</span> (<span>2020</span>) <span>Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting</span>. <i>ESC Heart Failure</i>, <span>7</span>: <span>1049</span>–<span>1055</span>. 10.1002/ehf2.12644.</p><p>In the abstract, in the last sentence of methods and results, the text ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038] and NT-proBNP ≥ median level (OR 0.48; 95% CI 0.26–0.90; <i>P</i> = 0.021) was associated with termination of the medication’ was incorrect. This should have read ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038] was associated with termination of the medication’.</p><p>Also, in page 1051, in the last paragraph of the results, the text ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038) and a NT-proBNP higher than the median level of 2,860 ng/L (OR 0.48; 95% CI 0.26–0.90; <i>P</i> = 0.021) predicted discontinuation of the treatment’ was wrong. This should have read ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038) predicted discontinuation of the treatment’.</p><p>We apologize for this error.</p>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":"12 2","pages":"1525"},"PeriodicalIF":3.2000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ehf2.15211","citationCount":"0","resultStr":"{\"title\":\"Correction to ‘Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting’\",\"authors\":\"\",\"doi\":\"10.1002/ehf2.15211\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>\\n <span>Nordberg Backelin, C.</span>, <span>Fu, M.</span>, and <span>Ljungman, C.</span> (<span>2020</span>) <span>Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting</span>. <i>ESC Heart Failure</i>, <span>7</span>: <span>1049</span>–<span>1055</span>. 10.1002/ehf2.12644.</p><p>In the abstract, in the last sentence of methods and results, the text ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038] and NT-proBNP ≥ median level (OR 0.48; 95% CI 0.26–0.90; <i>P</i> = 0.021) was associated with termination of the medication’ was incorrect. This should have read ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038] was associated with termination of the medication’.</p><p>Also, in page 1051, in the last paragraph of the results, the text ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038) and a NT-proBNP higher than the median level of 2,860 ng/L (OR 0.48; 95% CI 0.26–0.90; <i>P</i> = 0.021) predicted discontinuation of the treatment’ was wrong. This should have read ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; <i>P</i> = 0.038) predicted discontinuation of the treatment’.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":11864,\"journal\":{\"name\":\"ESC Heart Failure\",\"volume\":\"12 2\",\"pages\":\"1525\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ehf2.15211\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESC Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15211\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15211","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
Nordberg Backelin， C, Fu， M.和Ljungman， C.（2020）在现实世界的临床环境中，沙克比利-缬沙坦治疗心力衰竭并降低射血分数的早期经验。ESC心力衰竭，7:1049-1055。10.1002 / ehf2.12644。摘要在方法与结果的最后一句中，正文“女性性别[比值比（OR） 3.58；95% ci 1.07-2.00；P = 0.038]且NT-proBNP≥中位数水平(OR 0.48；95% ci 0.26-0.90；P = 0.021)与终止用药有关。这应该是“女性[比值比（OR） 3.58；95% ci 1.07-2.00；P = 0.038]与终止用药有关。同样，在1051页，在结果的最后一段，文本“年龄调整逻辑回归分析显示女性性别(OR 3.58；95% ci 1.07-2.00；P = 0.038)， NT-proBNP高于中位水平2,860 ng/L (OR 0.48；95% ci 0.26-0.90；P = 0.021)预测停止治疗是错误的。这应该是“年龄调整逻辑回归分析显示女性(OR 3.58；95% ci 1.07-2.00；P = 0.038)预测停药。我们为这个错误道歉。
Correction to ‘Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting’
Nordberg Backelin, C., Fu, M., and Ljungman, C. (2020) Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting. ESC Heart Failure, 7: 1049–1055. 10.1002/ehf2.12644.
In the abstract, in the last sentence of methods and results, the text ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; P = 0.038] and NT-proBNP ≥ median level (OR 0.48; 95% CI 0.26–0.90; P = 0.021) was associated with termination of the medication’ was incorrect. This should have read ‘Female gender [odds ratio (OR) 3.58; 95% CI 1.07–2.00; P = 0.038] was associated with termination of the medication’.
Also, in page 1051, in the last paragraph of the results, the text ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; P = 0.038) and a NT-proBNP higher than the median level of 2,860 ng/L (OR 0.48; 95% CI 0.26–0.90; P = 0.021) predicted discontinuation of the treatment’ was wrong. This should have read ‘Age-adjusted logistic regression analysis showed that female gender (OR 3.58; 95% CI 1.07–2.00; P = 0.038) predicted discontinuation of the treatment’.
期刊介绍：
ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
